226 related articles for article (PubMed ID: 95801)
1. Evaluation of the C1q solid-phase binding assay for immune complexes. A clinical and laboratory study.
Scullion M; Balint G; Whaley K
J Clin Lab Immunol; 1979 Apr; 2(1):15-22. PubMed ID: 95801
[TBL] [Abstract][Full Text] [Related]
2. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
3. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
4. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
6. [Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases].
Aleshkin VA; Nasonov EL; Eremeeva MV; Kobylianskiĭ AG
Ter Arkh; 1989; 61(6):113-6. PubMed ID: 2477907
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes in Hodgkin's disease: isolation, immunochemical and physico-chemical analysis.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1983 Aug; 53(2):308-18. PubMed ID: 6411401
[TBL] [Abstract][Full Text] [Related]
8. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
[TBL] [Abstract][Full Text] [Related]
9. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
[TBL] [Abstract][Full Text] [Related]
10. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
[TBL] [Abstract][Full Text] [Related]
11. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
Gabriel A; Agnello V
J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
[TBL] [Abstract][Full Text] [Related]
14. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
15. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
Kohro-Kawata J; Wener MH; Mannik M
J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
[TBL] [Abstract][Full Text] [Related]
16. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q.
Bengtsson A; Nezlin R; Shoenfeld Y; Sturfelt G
J Autoimmun; 1999 Aug; 13(1):111-9. PubMed ID: 10441175
[TBL] [Abstract][Full Text] [Related]
17. Failure to detect circulating DNA--anti-DNA complexes by four radioimmunological methods in patients with systemic lupus erythematosus.
Izui S; Lambert PH; Miescher PA
Clin Exp Immunol; 1977 Dec; 30(3):384-92. PubMed ID: 606451
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes in rheumatoid arthritis: a prospective study using five immunoassays.
Reynolds WJ; Yoon SJ; Emin M; Chapman KR; Klein MH
J Rheumatol; 1986 Aug; 13(4):700-6. PubMed ID: 3490573
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
20. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody.
Tron F; Letarte J; Roque-Antunes Barreira MC; Lesavre P
Clin Exp Immunol; 1982 Aug; 49(2):481-7. PubMed ID: 6982138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
